IDEAL DIABETES CICActive

Company number 12709586Community interest companyIncorporated 2020

Key figures

£4,477+70.5%
Net assets 2024/25
+30.4%
Average annual growth 2020/21–2024/25
02 k4 k6 k2020/212021/222022/232023/242024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Turnover24,50053,00056,48561,99928,000
Cash at bank and in hand16,9992,87329,56231,4525,714
Total assets16,9992,87329,56231,4525,714
Total liabilities15,45059227,15928,8261,237
Net assets / total equity1,5492,2812,4032,6264,477
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The company's principal activity during the period was to improve care pathways for people with diabetes.

As described in the company's latest filed accounts.

Summary: IDEAL DIABETES CIC

Company

IDEAL DIABETES CIC is a community interest company registered with Companies House under company number 12709586. It was incorporated on 1 Jul 2020. Its status is active. The registered office is in Kingsbridge (TQ7). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Turnover was £28,000. Net assets were £4,477, up 70.5% on the previous year. Cash at bank and in hand was £5,714. Total assets were £5,714 and total liabilities £1,237. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 9 Jul 2027.